You can:
Name | Somatostatin receptor type 2 |
---|---|
Species | Homo sapiens (Human) |
Gene | SSTR2 |
Synonym | somatotropin release-inhibiting factor receptor SRIF-1 SS-2-R SS2-R SS2R [ Show all ] |
Disease | Acromegaly Lung cancer Neuroendocrine cancer |
Length | 369 |
Amino acid sequence | MDMADEPLNGSHTWLSIPFDLNGSVVSTNTSNQTEPYYDLTSNAVLTFIYFVVCIIGLCGNTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMITMAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYTFILGFLVPLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSMAISPTPALKGMFDFVVVLTYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGTDDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI |
UniProt | P30874 |
Protein Data Bank | N/A |
GPCR-HGmod model | P30874 |
3D structure model | This predicted structure model is from GPCR-EXP P30874. |
BioLiP | N/A |
Therapeutic Target Database | T53024 |
ChEMBL | CHEMBL1804 |
IUPHAR | 356 |
DrugBank | BE0003528 |
Name | Lanreotide |
---|---|
Molecular formula | C54H69N11O10S2 |
IUPAC name | (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide |
Molecular weight | 1096.33 |
Hydrogen bond acceptor | 14 |
Hydrogen bond donor | 13 |
XlogP | 2.5 |
Synonyms | 3-(2-Naphthyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide cyclic (27)-disulfide Bim-23014 Lanreotide Autogel 108736-35-2 AC1OCEWT [ Show all ] |
Inchi Key | PUDHBTGHUJUUFI-SCTWWAJVSA-N |
Inchi ID | InChI=1S/C54H69N11O10S2/c1-29(2)45-54(75)63-44(53(74)65-46(30(3)66)47(57)68)28-77-76-27-43(62-48(69)38(56)23-32-15-18-33-10-4-5-11-34(33)22-32)52(73)60-41(24-31-16-19-36(67)20-17-31)50(71)61-42(25-35-26-58-39-13-7-6-12-37(35)39)51(72)59-40(49(70)64-45)14-8-9-21-55/h4-7,10-13,15-20,22,26,29-30,38,40-46,58,66-67H,8-9,14,21,23-25,27-28,55-56H2,1-3H3,(H2,57,68)(H,59,72)(H,60,73)(H,61,71)(H,62,69)(H,63,75)(H,64,70)(H,65,74)/t30-,38-,40+,41+,42-,43+,44+,45+,46+/m1/s1 |
PubChem CID | 6918011 |
ChEMBL | CHEMBL1201185 |
IUPHAR | N/A |
BindingDB | 82470 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
Ki | 0.21 nM | PMID9652348 | BindingDB |
Ki | 0.28 nM | PMID10598788, PMID9652348 | BindingDB |
Ki | 0.37 nM | PMID10598788 | BindingDB |
Ki | 0.5 nM | PMID9290757 | BindingDB |
Ki | 0.5 nM | PMID8769372 | BindingDB |
Ki | 0.5012 nM | PMID12773038 | ChEMBL |
Ki | 0.53 nM | PMID10598788, PMID9652348 | BindingDB |
Ki | 0.54 nM | PMID10598788, PMID9650799 | BindingDB |
Ki | 0.55 nM | PMID9650799 | BindingDB |
Ki | 0.75 nM | PMID9045884 | BindingDB |
Ki | 1.38 nM | PMID9652348 | BindingDB |
Ki | 1.8 nM | PMID7988476 | BindingDB |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417